4-methoxyamphetamine has been researched along with Head and Neck Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, WJ; Chen, MM; Chinn, SB; Lenze, N; Taylor, JMG; Worden, FP; Yalamanchi, P | 1 |
| Chino, F; Chino, J; Mowery, YM; Niedzwiecki, D; Stephens, SJ; Williamson, H | 1 |
| Dixon, L; Garcez, K; Lee, LW; Slevin, N; Sykes, A; Thomson, D | 1 |
3 other study(ies) available for 4-methoxyamphetamine and Head and Neck Neoplasms
| Article | Year |
|---|---|
Impact of monoclonal antibody therapy for head and neck cancer on end-of-life care utilization and costs.
Topics: Aged; Death; Head and Neck Neoplasms; Health Care Costs; Humans; Medicare; Nivolumab; Retrospective Studies; Terminal Care; United States | 2023 |
Evaluating for disparities in place of death for head and neck cancer patients in the United States utilizing the CDC WONDER database.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Black or African American; Centers for Disease Control and Prevention, U.S.; Confidence Intervals; Databases, Factual; Death; Female; Head and Neck Neoplasms; Hospices; Humans; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Odds Ratio; Regression Analysis; Residence Characteristics; Sex Distribution; United States; White People | 2020 |
Ninety Day Mortality After Radical Radiotherapy for Head and Neck Cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Death; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis | 2017 |